Paper20107007
Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice.
Mielcarek N and 3 others. Clin Vaccine Immunol, 2010. Cited by 29 papers, by iCite.
Cite this record
ConductScience Library. Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Papers, record 20107007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20107007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Pertussis Vaccine | Major topic |
| Administration, Intranasal | |
| Animals | |
| Antibodies, Bacterial | |
| Bordetella pertussis | |
| Enzyme-Linked Immunosorbent Assay | |
| Female | |
| Mice | |
| Mice, Inbred BALB C | |
| Vaccines, Attenuated | |
| Whooping Cough |
Source PubMed
Trials3
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record | Source |
|---|---|---|---|---|
| NCT01188512 | First Adult Safety Trial on Nasal Live Attenuated B. Pertussis Vaccine | Background | ClinicalTrials.gov | |
| NCT02453048 | Study of BPZE1 (High Dose) Nasal Live Attenuated B. Pertussis Vaccine | Background | ClinicalTrials.gov | |
| NCT03942406 | Study of BPZE1 Intranasal Pertussis Vaccine (Administered Via VaxINator(TM)), Prime + Boost, in Healthy Adults | Background | ClinicalTrials.gov |
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15876930 | Potential strategies to reduce the burden of pertussis. | Pediatr Infect Dis J | 2005 | https://conductscience.org/library/papers/15876930 | PubMed |
| 2 | 2407655 | Construction and characterization in vivo of Bordetella pertussis aroA mutants. | Infect Immun | 1990 | https://conductscience.org/library/papers/2407655 | PubMed |
| 3 | 19751581 | Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. | Emerg Infect Dis | 2009 | https://conductscience.org/library/papers/19751581 | PubMed |
| 4 | 2341166 | Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. | Infect Immun | 1990 | https://conductscience.org/library/papers/2341166 | PubMed |
| 5 | 18505398 | Factors contributing to pertussis resurgence. | Future Microbiol | 2008 | https://conductscience.org/library/papers/18505398 | PubMed |
| 6 | 12192169 | Retrospective population-based assessment of medically attended injection site reactions, seizures, allergic responses and febrile episodes after acellular pertussis vaccine combined with diphtheria and tetanus toxoids. | Pediatr Infect Dis J | 2002 | https://conductscience.org/library/papers/12192169 | PubMed |
| 7 | 2956754 | Prevention of atrophic rhinitis in piglets by means of intranasal administration of a live non-AR-pathogenic Bordetella bronchiseptica vaccine. | Vet Q | 1987 | https://conductscience.org/library/papers/2956754 | PubMed |
| 8 | 11447159 | Immunoglobulin A-mediated protection against Bordetella pertussis infection. | Infect Immun | 2001 | https://conductscience.org/library/papers/11447159 | PubMed |
| 9 | 12538714 | Bordetella pertussis infection in 2-month-old infants promotes type 1 T cell responses. | J Immunol | 2003 | https://conductscience.org/library/papers/12538714 | PubMed |
| 10 | 11964852 | Pertussis: an old disease that is still with us. | Curr Opin Infect Dis | 2001 | https://conductscience.org/library/papers/11964852 | PubMed |
| 11 | 10392618 | Intranasal murine model of Bordetella pertussis infection. I. Prediction of protection in human infants by acellular vaccines. | Vaccine | 1999 | https://conductscience.org/library/papers/10392618 | PubMed |
| 12 | 6315733 | Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. | J Biol Chem | 1983 | https://conductscience.org/library/papers/6315733 | PubMed |
| 13 | 12728086 | Immunogenicity of a three-component acellular pertussis vaccine administered at birth. | Pediatrics | 2003 | https://conductscience.org/library/papers/12728086 | PubMed |
| 14 | 17878939 | Comparative genomics of Bordetella pertussis reveals progressive gene loss in Finnish strains. | PLoS One | 2007 | https://conductscience.org/library/papers/17878939 | PubMed |
| 15 | 18560590 | Genomic content of Bordetella pertussis clinical isolates circulating in areas of intensive children vaccination. | PLoS One | 2008 | https://conductscience.org/library/papers/18560590 | PubMed |
| 16 | 525927 | Intranasal immunization of dogs against Bordetella bronchiseptica-induced tracheobronchitis (kennel cough) with modified live-Bordetella bronchiseptica vaccine. | Am J Vet Res | 1979 | https://conductscience.org/library/papers/525927 | PubMed |
| 17 | 15788498 | Clinical practice. Pertussis--not just for kids. | N Engl J Med | 2005 | https://conductscience.org/library/papers/15788498 | PubMed |
| 18 | 8112848 | Heparin-inhibitable lectin activity of the filamentous hemagglutinin adhesin of Bordetella pertussis. | Infect Immun | 1994 | https://conductscience.org/library/papers/8112848 | PubMed |
| 19 | 14449563 | Experimental Whooping cough. | N Engl J Med | 1962 | https://conductscience.org/library/papers/14449563 | PubMed |
| 20 | 9009311 | Intranasal priming with recombinant Bordetella pertussis for the induction of a systemic immune response against a heterologous antigen. | Infect Immun | 1997 | https://conductscience.org/library/papers/9009311 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 29 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40612502 | Protection of infant mice against pertussis, tuberculosis and influenza by co-administration of nasal pertussis vaccine candidate BPZE1 and BCG. | iScience | 2025 | https://conductscience.org/library/papers/40612502 | PubMed |
| 34276113 | Antibodies induced by oral immunization of mice with a recombinant protein produced in tobacco plants harboring Bordetella pertussis epitopes. | Plant Cell Tissue Organ Cult | 2021 | https://conductscience.org/library/papers/34276113 | PubMed |
| 34211481 | Mucosal Immunization Against Pertussis: Lessons From the Past and Perspectives. | Front Immunol | 2021 | https://conductscience.org/library/papers/34211481 | PubMed |
| 33318136 | Intranasal Immunization with Acellular Pertussis Vaccines Results in Long-Term Immunity to Bordetella pertussis in Mice. | Infect Immun | 2021 | https://conductscience.org/library/papers/33318136 | PubMed |
| 31921136 | Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections. | Front Immunol | 2019 | https://conductscience.org/library/papers/31921136 | PubMed |
| 30115992 | IL-17-dependent SIgA-mediated protection against nasal Bordetella pertussis infection by live attenuated BPZE1 vaccine. | Mucosal Immunol | 2018 | https://conductscience.org/library/papers/30115992 | PubMed |
| 29531137 | The Adjuvant Bordetella Colonization Factor A Attenuates Alum-Induced Th2 Responses and Enhances Bordetella pertussis Clearance from Mouse Lungs. | Infect Immun | 2018 | https://conductscience.org/library/papers/29531137 | PubMed |
| 29125532 | A New Whooping Cough Vaccine That May Prevent Colonization and Transmission. | Vaccines (Basel) | 2017 | https://conductscience.org/library/papers/29125532 | PubMed |
| 26542059 | Protecting Newborns Against Pertussis: Treatment and Prevention Strategies. | Paediatr Drugs | 2015 | https://conductscience.org/library/papers/26542059 | PubMed |
| 24421886 | A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers. | PLoS One | 2014 | https://conductscience.org/library/papers/24421886 | PubMed |
| 24261996 | Attenuated Bordetella pertussis vaccine protects against respiratory syncytial virus disease via an IL-17-dependent mechanism. | Am J Respir Crit Care Med | 2014 | https://conductscience.org/library/papers/24261996 | PubMed |
| 23555631 | Immunogenicity of live attenuated B. pertussis BPZE1 producing the universal influenza vaccine candidate M2e. | PLoS One | 2013 | https://conductscience.org/library/papers/23555631 | PubMed |
| 21147936 | A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. | Clin Vaccine Immunol | 2011 | https://conductscience.org/library/papers/21147936 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20107007
GET https://conductscience.org/api/papers/v1/20107007/references?page=2